Literature DB >> 28119540

Osteoarthritis in 2016: Anti-NGF treatments for pain - two steps forward, one step back?

Nancy E Lane1, Maripat Corr2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28119540     DOI： 10.1038/nrrheum.2016.224

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  8 in total

Review 1.  A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee.

Authors:  T J Schnitzer; J A Marks
Journal:  Osteoarthritis Cartilage       Date:  2015-01       Impact factor: 6.576

2.  Tanezumab for the treatment of pain from osteoarthritis of the knee.

Authors:  Nancy E Lane; Thomas J Schnitzer; Charles A Birbara; Masoud Mokhtarani; David L Shelton; Mike D Smith; Mark T Brown
Journal:  N Engl J Med       Date:  2010-09-29       Impact factor: 91.245

3.  Nerve growth factor downregulates inflammatory response in human monocytes through TrkA.

Authors:  Giusi Prencipe; Gaetana Minnone; Raffaele Strippoli; Loredana De Pasquale; Stefania Petrini; Ivan Caiello; Luigi Manni; Fabrizio De Benedetti; Luisa Bracci-Laudiero
Journal:  J Immunol       Date:  2014-02-28       Impact factor: 5.422

4.  TLR2 is required for the altered transcription of p75NGF receptors in gram positive infection.

Authors:  Sebastian A Wirz; Peter S Tobias; Richard J Ulevitch; Laurence Aribibe; Tamas Bartfai
Journal:  Neurochem Res       Date:  2006-03-03       Impact factor: 3.996

Review 5.  Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor.

Authors:  Joseph K Eibl; Bridget C Strasser; Gregory M Ross
Journal:  Neurochem Int       Date:  2012-10-26       Impact factor: 3.921

6.  Nerve growth factor promotes TLR4 signaling-induced maturation of human dendritic cells in vitro through inducible p75NTR 1.

Authors:  Yingming Jiang; Guoyou Chen; Yi Zhang; Lin Lu; Shuxun Liu; Xuetao Cao
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

7.  Nerve Growth Factor Is Regulated by Toll-Like Receptor 2 in Human Intervertebral Discs.

Authors:  Emerson Krock; J Brooke Currie; Michael H Weber; Jean A Ouellet; Laura S Stone; Derek H Rosenzweig; Lisbet Haglund
Journal:  J Biol Chem       Date:  2015-12-14       Impact factor: 5.157

8.  When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program.

Authors:  Marc C Hochberg; Leslie A Tive; Steven B Abramson; Eric Vignon; Kenneth M Verburg; Christine R West; Michael D Smith; David S Hungerford
Journal:  Arthritis Rheumatol       Date:  2016-02       Impact factor: 10.995
  8 in total
  19 in total

Review 1.  Cartilage diseases.

Authors:  Yamini Krishnan; Alan J Grodzinsky
Journal:  Matrix Biol       Date:  2018-05-24       Impact factor: 11.583

Review 2.  What is new in pain modification in osteoarthritis?

Authors:  Rachel E Miller; Joel A Block; Anne-Marie Malfait
Journal:  Rheumatology (Oxford)       Date:  2018-05-01       Impact factor: 7.580

Review 3.  Targeting neurotrophic factors: Novel approaches to musculoskeletal pain.

Authors:  Anne-Marie Malfait; Rachel E Miller; Joel A Block
Journal:  Pharmacol Ther       Date:  2020-04-18       Impact factor: 12.310

Review 4.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

5.  Acupuncture reduces pain in rats with osteoarthritis by inhibiting MCP2/CCR2 signaling pathway.

Authors:  Bocun Li; Li Jing; Li Jia; Tan Qian; Chen Jianyi; Huang Zhongsheng; Zhou Xiaohong; Cai Guowei
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 6.  Peripheral Mechanisms Contributing to Osteoarthritis Pain.

Authors:  Delfien Syx; Phuong B Tran; Rachel E Miller; Anne-Marie Malfait
Journal:  Curr Rheumatol Rep       Date:  2018-02-26       Impact factor: 4.592

Review 7.  Current status of nerve growth factor antibodies for the treatment of osteoarthritis pain.

Authors:  Rachel E Miller; Anne-Marie Malfait; Joel A Block
Journal:  Clin Exp Rheumatol       Date:  2017-09-28       Impact factor: 4.473

8.  Molecular modelling studies of quinazolinone derivatives as MMP-13 inhibitors by QSAR, molecular docking and molecular dynamics simulations techniques.

Authors:  Shanshan Huang; Kairui Feng; Yujie Ren
Journal:  Medchemcomm       Date:  2018-11-13       Impact factor: 3.597

9.  Plasma and Joint Fluid Glypican-3 Are Inversely Correlated with the Severity of Knee Osteoarthritis.

Authors:  Wanvisa Udomsinprasert; Ellie McConachie; Srihatach Ngarmukos; Nipaporn Theerawattanapong; Aree Tanavalee; Sittisak Honsawek
Journal:  Cartilage       Date:  2019-04-04       Impact factor: 4.634

Review 10.  Molecular and structural imaging in surgically induced murine osteoarthritis.

Authors:  N H Lim; C Wen; T L Vincent
Journal:  Osteoarthritis Cartilage       Date:  2020-04-16       Impact factor: 6.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.